Latest On Nektar Therapeutics (NKTR):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-10 05:35 EST | News | Nektar Therapeutics (NKTR) Q1 2023 Earnings Call Transcript | N/A |  |
| 2023-05-09 02:38 EST | News | Nektar Therapeutics Q1 2023 Earnings Preview | N/A | |
| 2023-04-27 21:26 EST | News | Nektar regains rights to atopic dermatitis candidate from Eli Lilly | N/A | |
| 2023-04-18 13:18 EST | News | Nektar Chief Medical Officer Brian Kotzin, CFO Jillian Thomsen to step down | N/A | |
| 2023-04-18 00:22 EST | News | Nektar Therapeutics up 7% after hours on restructuring plan | N/A | |
| 2023-03-30 08:08 EST | News | Nektar Therapeutics slips, PacWest Bancorp gains on S&P index moves | N/A | |
| 2023-02-28 23:25 EST | News | Nektar Therapeutics GAAP EPS of -$0.32 beats by $0.13, revenue of $22.02M misses by $0.19M | N/A | |
| 2023-02-24 20:38 EST | News | Nektar sheds 45% as trial setback prompts Jefferies downgrade | N/A | |
| 2023-02-24 20:37 EST | News | Nektar Therapeutics: Another Clinical Failure Nearly Wipes Out The R&D Value | N/A | |
| 2023-02-24 06:55 EST | News | Nektar Therapeutics plunges 29% after hours on mid-stage lupus treatment failure | N/A | |
| 2023-02-16 16:40 EST | News | Nektar Therapeutics Looking To Rebuild Faith In Its Now Early-Stage Pipeline | N/A | |
| 2022-11-18 18:16 EST | News | Nektar Therapeutics: Recovery Seems To Be A Mirage | N/A | |
| 2022-11-04 06:11 EST | News | Nektar Therapeutics GAAP EPS of -$0.31 beats by $0.15, revenue of $23.63M beats by $1.02M | N/A | |
| 2022-11-04 06:11 EST | News | Nektar Therapeutics (NKTR) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-02 21:07 EST | News | Nektar Therapeutics Q3 2022 Earnings Preview | N/A | |
| 2022-10-07 19:21 EST | News | PureTech Health plunges 21% after confirming proposal from Nektar Therapeutics (update) | N/A | |
| 2022-08-09 05:53 EST | News | Nektar downgraded at JPMorgan citing setup after end to anti-cancer program | N/A | |
| 2022-08-05 05:55 EST | News | Nektar Therapeutics GAAP EPS of -$0.85 beats by $0.15, revenue of $21.6M misses by $1.15M | N/A | |
| 2022-08-04 00:03 EST | News | Nektar Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-07-18 01:35 EST | News | Nektar: Time To Abandon Ship | N/A | |
| 2022-07-01 08:36 EST | News | Nektar promotes internal executive to CFO role | N/A | |
| 2022-05-06 05:46 EST | News | Nektar Therapeutics GAAP EPS of -$0.49 beats by $0.21, revenue of $24.8M misses by $0.09M | N/A | |
| 2022-04-26 00:40 EST | News | Nektar Therapeutics unveils restructuring plan, laying off 70% of its workforce | N/A | |
| 2022-04-25 08:13 EST | News | Nektar cancer drug improves anti-tumor effect of CAR T drugs | N/A | |
| 2022-04-18 18:35 EST | News | Nektar stock slumps 36% on Goldman Sachs downgrade following bempeg program termination | N/A | |
| 2022-04-15 01:59 EST | News | Nektar, Bristol Myers to end development program for bempegaldesleukin/Opdivo combo | N/A | |
| 2022-04-04 21:06 EST | News | After A High-Profile Failure In Melanoma, Nektar Therapeutics' Value Shifts To Its Early-Stage Pipeline | N/A | |
| 2022-03-16 07:09 EST | News | Nektar draws more downgrades after setback for melanoma trial | N/A | |
| 2022-03-14 14:26 EST | News | Nektar stock slumps ~50% after phase 3 trial in skin cancer with Bristol Myers fails | N/A | |
| 2022-03-14 14:26 EST | News | Nektar hit by “major” setback with melanoma trial failure for lead asset - BofA | N/A | |
| 2022-03-09 10:24 EST | News | Nektar Therapeutics upgraded at Oppenheimer based on favorable risk/reward | N/A | |
| 2022-03-01 10:31 EST | News | Nektar Therapeutics' (NKTR) CEO Howard Robin on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-27 20:45 EST | News | Nektar Therapeutics Q4 2021 Earnings Preview | N/A | |
| 2022-02-15 08:02 EST | News | Druckenmiller's Duquesne adds Willscot Mobile Mini, exits Nektar Therapeutics | N/A | |
| 2022-01-26 08:48 EST | News | Nektar Therapeutics: Beaten Down By 2021 | N/A | |
| 2021-12-15 15:28 EST | News | Nektar Therapeutics reports phase 1b data for NKTR-358 study in atopic dermatitis | N/A | |
| 2021-11-10 12:56 EST | News | Nektar: The Anatomy Of A Shakedown | N/A | |
| 2021-11-05 10:44 EST | News | Nektar Therapeutics EPS beats by $0.10, misses on revenue | N/A | |
| 2021-11-05 10:44 EST | News | Nektar Therapeutics (NKTR) CEO Howard Robin on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-05 10:43 EST | News | Nektar Therapeutics shares slide 22% after Q3 topline miss, cash position update | N/A | |
| 2021-11-04 13:39 EST | News | Nektar Therapeutics Q3 2021 Earnings Preview | N/A | |
| 2021-09-29 20:12 EST | News | Nektar Therapeutics' Short Covering Surges By 200% In 2 Weeks | N/A | |
| 2021-09-23 08:24 EST | News | Nektar Sends Shot Across Bristol Myers Squibb's Bow With Big Pfizer Collaboration | N/A | |
| 2021-09-22 01:59 EST | News | Nektar And Bristol Myers Squibb Expecting Bempeg Approval | N/A | |
| 2021-09-22 01:54 EST | News | Nektar Therapeutics enters oncology clinical collaboration with Merck KGaA and Pfizer | N/A | |
| 2021-09-11 01:36 EST | News | Nektar Therapeutics’ experimental cancer therapy requires “significant derisking” - BofA | N/A | |
| 2021-08-27 13:17 EST | News | Mr. Manipulation Meets Ms. Opportunity At The Nektar Cocktail Party | N/A | |
| 2021-08-06 07:48 EST | News | Nektar Therapeutics EPS beats by $0.04, beats on revenue | N/A | |
| 2021-08-06 07:48 EST | News | Key data readouts for Nektar lead candidate on schedule for later this year, 2022 | N/A | |
| 2021-08-06 07:47 EST | News | Nektar Therapeutics (NKTR) CEO Howard Robin on Q2 2021 Results - Earnings Call Transcript | N/A | |
About Nektar Therapeutics (NKTR):
Nektar Therapeutics, a biopharmaceutical company, researches and develops drug candidates for cancer and auto-immune disease in the United States. The company develops Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of non-small cell lung cancer and immuno-oncology; and phase 1B clinical trial to treat COVID-19.It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat locally advanced or metastatic solid tumor malignancies, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.
General
- Name Nektar Therapeutics
- Symbol NKTR
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 718
- Last Split Factor2:1
- Last Split Date2000-08-23
- Fiscal Year EndDecember
- IPO Date1994-05-03
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.nektar.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 26.65
- Price/Book (Most Recent Quarter) 3.86
- Enterprise Value Revenue 21.23
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.99
- Next Year EPS Estimate -$2.44
- Next Quarter EPS Estimate -$0.67
- Profit Margin -291%
- Operating Margin -248%
- Return on Assets -14%
- Return on Equity -36%
- Revenue 152.92 million
- Earnings Per Share -$2.44
- Revenue Per Share $0.86
- Gross Profit 133.44 million
- Quarterly Earnings Growth -30.7%
View More
Highlights
- Market Capitalization 4.13 billion
- EBITDA -418699008
- PE Ratio -1.33
- PEG Ratio 3.22
- Analyst Target Price $31
- Book Value Per Share $5.98
View More
Share Statistics
- Shares Outstanding 182.29 million
- Shares Float 180.17 million
- % Held by Insiders 87%
- % Held by Institutions 97.79%
- Shares Short 21.25 million
- Shares Short Prior Month 21.16 million
- Short Ratio 11.66
- Short % of Float 23%
- Short % of Shares Outstanding 12%
View More
Technicals
- Beta 1.64
- 52 Week High $26.75
- 52 Week Low $15.4
- 50 Day Moving Average 22.13
- 200 Day Moving Average 18.82
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Nektar Therapeutics (NKTR) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Nektar Therapeutics (NKTR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | -$0.65 | -$0.75 | 13.55% |
| 2020-09-30 | 2020-11-05 | $30.03 million | -$0.61 | -$0.75 | 18.87% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.45 | -$0.69 | 34.57% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.78 | -$0.74 | -5.15% |
| 2019-12-31 | 2020-02-27 | $33.86 million | -$0.64 | -$0.69 | 6.8% |
| 2019-09-30 | 2019-11-06 | $29.22 million | -$0.56 | -$0.72 | 22.41% |
| 2019-06-30 | 2019-08-08 | $23.32 million | -$0.63 | -$0.80 | 21.25% |
| 2019-03-31 | 2019-05-08 | $28.22 million | -$0.68 | -$0.76 | 10.08% |
| 2018-12-31 | 2019-02-28 | $39.83 million | -$0.57 | -$0.63 | 10.17% |
| 2018-09-30 | 2018-11-07 | $27.76 million | -$0.56 | -$0.63 | 11.17% |
| 2018-06-30 | 2018-08-08 | $1.09 billion | $5.33 | $5.29 | 0.82% |
| 2018-03-31 | 2018-05-10 | $38.02 million | -$0.60 | -$0.55 | -9.75% |
| 2017-12-31 | 2018-03-01 | $95.47 million | -$0.21 | -$0.36 | 41.89% |
| 2017-09-30 | 2017-11-07 | $152.93 million | $0.37 | $0.22 | 65.33% |
| 2017-06-30 | 2017-08-08 | $34.59 million | -$0.39 | -$0.36 | -7.38% |
| 2017-03-31 | 2017-05-09 | $24.73 million | -$0.42 | -$0.42 | 0.38% |
| 2016-12-31 | 2017-03-01 | $37.45 million | -$0.28 | -$0.27 | -4.83% |
| 2016-09-30 | 2016-11-03 | $36.34 million | -$0.32 | -$0.36 | 11.11% |
| 2016-06-30 | 2016-08-03 | $32.77 million | -$0.36 | -$0.33 | -8.96% |
| 2016-03-31 | 2016-05-03 | $58.88 million | -$0.14 | -$0.26 | 46.89% |
| 2015-12-31 | 2016-03-01 | $39.37 million | -$0.30 | -$0.41 | 27.26% |
| 2015-09-30 | 2015-11-05 | $59.95 million | -$0.06 | -$0.24 | 75% |
| 2015-06-30 | 2015-08-05 | $22.66 million | -$0.40 | -$0.40 | 0% |
| 2015-03-31 | 2015-04-30 | $108.8 million | $0.25 | -$0.40 | 162.5% |
| 2014-12-31 | 2015-02-24 | $19.55 million | -$0.35 | -$0.36 | 2.78% |
| 2014-09-30 | 2014-11-06 | $132.87 million | $0.53 | $0.39 | 35.9% |
| 2014-06-30 | 2014-07-31 | $28.51 million | -$0.26 | -$0.37 | 29.73% |
| 2014-03-31 | 2014-05-07 | $19.77 million | -$0.37 | -$0.31 | -19.35% |
| 2013-12-31 | 2014-02-26 | $31.15 million | -$0.41 | -$0.17 | -141.18% |
| 2013-09-30 | 2013-11-07 | $60.91 million | -$0.14 | -$0.22 | 36.36% |
| 2013-06-30 | 2013-08-08 | $33.86 million | -$0.37 | -$0.44 | 15.91% |
| 2013-03-31 | 2013-05-09 | $23 million | -$0.48 | -$0.42 | -14.29% |
| 2012-12-31 | 2013-02-28 | $21.15 million | -$0.46 | -$0.45 | -2.22% |
| 2012-09-30 | 2012-11-09 | $18.41 million | -$0.38 | -$0.39 | 2.56% |
| 2012-06-30 | 2012-08-09 | $23.68 million | -$0.30 | -$0.34 | 11.76% |
| 2012-03-31 | 2012-05-02 | $17.95 million | -$0.34 | -$0.33 | -3.03% |
| 2011-12-31 | 2012-02-29 | $15.78 million | -$0.33 | -$0.48 | 31.25% |
| 2011-09-30 | 2011-11-02 | $27.07 million | -$0.21 | -$0.37 | 43.24% |
| 2011-06-30 | 2011-08-04 | $17.33 million | -$0.32 | -$0.33 | 3.03% |
| 2011-03-31 | 2011-04-27 | $11.3 million | -$0.33 | -$0.27 | -22.22% |
| 2010-12-31 | 2011-03-01 | $45.31 million | -$0.11 | -$0.16 | 31.25% |
| 2010-09-30 | 2010-11-04 | $37.93 million | -$0.09 | -$0.05 | -80% |
| 2010-06-30 | 2010-07-28 | $42.56 million | -$0.01 | -$0.08 | 87.5% |
| 2010-03-31 | 2010-05-05 | $33.24 million | -$0.07 | -$0.09 | 22.22% |
| 2009-12-31 | 2010-03-02 | $39.01 million | -$0.08 | $0.02 | -500% |
| 2009-09-30 | 2009-11-04 | $10.22 million | -$0.33 | -$0.38 | 13.16% |
| 2009-06-30 | 2009-08-04 | $12.99 million | -$0.35 | -$0.41 | 14.63% |
| 2009-03-31 | 2009-05-06 | $9.71 million | -$0.34 | -$0.41 | 17.07% |
| 2008-12-31 | 2009-02-24 | $28.35 million | -$0.45 | -$0.31 | -45.16% |
| 2008-09-30 | 2008-11-06 | $21.44 million | -$0.40 | -$0.29 | -37.93% |
| 2008-06-30 | 2008-08-06 | $20.4 million | -$0.36 | -$0.31 | -16.13% |
| 2008-03-31 | 2008-05-07 | $19.99 million | -$0.44 | -$0.25 | -76% |
| 2007-12-31 | 2008-02-27 | $65.77 million | -$0.11 | -$0.23 | 52.17% |
| 2007-09-30 | 2007-11-07 | $56.32 million | -$0.20 | -$0.30 | 33.33% |
| 2007-06-30 | 2007-08-08 | $65.92 million | -$0.30 | -$0.30 | 0% |
| 2007-03-31 | 2007-05-09 | $85.02 million | -$0.28 | -$0.34 | 17.65% |
| 2006-12-31 | 2007-02-28 | $69.9 million | -$0.37 | -$0.39 | 5.13% |
| 2006-09-30 | 2006-11-02 | $58.63 million | -$0.19 | -$0.37 | 48.65% |
| 2006-06-30 | 2006-08-03 | $60.22 million | -$0.34 | -$0.37 | 8.11% |
| 2006-03-31 | 2006-05-10 | $28.96 million | -$0.33 | -$0.39 | 15.38% |
| 2005-12-31 | 2006-02-28 | $32.88 million | -$0.40 | -$0.38 | -5.26% |
| 2005-09-30 | 2005-11-03 | $36.35 million | -$0.28 | -$0.37 | 24.32% |
| 2005-06-30 | 2005-08-04 | $28.55 million | -$0.32 | -$0.34 | 5.88% |
| 2005-03-31 | 2005-05-09 | $28.49 million | -$0.31 | -$0.29 | -6.9% |
| 2004-12-31 | 2005-03-01 | $31.37 million | -$0.23 | -$0.27 | 14.81% |
| 2004-09-30 | 2004-11-03 | $28.55 million | -$0.24 | -$0.26 | 7.69% |
| 2004-06-30 | 2004-08-02 | $28.53 million | -$0.27 | -$0.28 | 3.57% |
| 2004-03-31 | 2004-05-05 | $25.83 million | -$0.29 | -$0.39 | 25.64% |
| 2003-12-31 | 2004-02-02 | $25.62 million | -$0.38 | -$0.48 | 20.83% |
| 2003-09-30 | 2003-11-05 | $27.36 million | -$0.31 | -$0.52 | 40.38% |
| 2003-06-30 | 2003-08-06 | $27.75 million | -$0.23 | -$0.46 | 50% |
| 2003-03-31 | 2003-04-22 | $25.53 million | -$0.36 | -$0.43 | 16.28% |
| 2002-12-31 | 2003-01-28 | $22.63 million | -$0.51 | -$0.52 | 1.92% |
| 2002-09-30 | 2002-10-22 | $23.22 million | -$0.48 | -$0.50 | 4% |
| 2002-06-30 | 2002-07-23 | $22.25 million | -$0.44 | -$0.46 | 4.35% |
| 2002-03-31 | 2002-05-02 | $26.75 million | -$0.45 | -$0.44 | -2.27% |
| 2001-12-31 | 2002-01-23 | $24.17 million | -$0.37 | -$0.37 | 0% |
| 2001-09-30 | 2001-10-24 | $22.41 million | -$0.33 | -$0.35 | 5.71% |
| 2001-06-30 | 2001-08-08 | $16.8 million | -$0.34 | -$0.36 | 5.56% |
| 2001-03-31 | 2001-05-01 | $14.1 million | -$0.30 | -$0.34 | 11.76% |
| 2000-12-31 | 2001-01-24 | $13.15 million | -$0.31 | -$0.33 | 6.06% |
| 2000-09-30 | 2000-10-23 | $14.06 million | -$0.29 | -$0.27 | -7.41% |
| 2000-06-30 | 2000-07-19 | $13.79 million | -$0.28 | -$0.29 | 3.45% |
| 2000-03-31 | 2000-04-19 | $10.63 million | -$0.28 | -$0.29 | 3.45% |
| 1999-12-31 | 2000-01-26 | -$0.30 | -$0.29 | -3.45% | |
| 1999-09-30 | 1999-10-25 | -$0.20 | -$0.19 | -5.26% | |
| 1999-06-30 | 1999-07-22 | -$0.17 | -$0.17 | 0% | |
| 1999-03-31 | 1999-04-21 | -$0.15 | -$0.16 | 6.25% | |
| 1998-12-31 | 1999-01-26 | -$0.19 | -$0.19 | 0% | |
| 1998-09-30 | 1998-10-22 | -$0.16 | -$0.16 | 0% | |
| 1998-06-30 | 1998-07-22 | -$0.09 | -$0.14 | 35.71% | |
| 1998-03-31 | 1998-04-21 | -$0.13 | -$0.13 | 0% | |
| 1997-12-31 | 1998-01-22 | -$0.10 | -$0.15 | 33.33% | |
| 1997-09-30 | 1997-10-06 | -$0.09 | -$0.15 | 40% | |
| 1997-06-30 | 1997-07-24 | -$0.08 | -$0.12 | 33.33% | |
| 1997-03-31 | 1997-04-24 | -$0.08 | -$0.13 | 38.46% | |
| 1996-12-31 | 1997-01-31 | -$0.14 | -$0.16 | 12.5% | |
| 1996-09-30 | 1996-10-22 | -$0.10 | -$0.15 | 33.33% | |
| 1996-06-30 | 1996-07-24 | -$0.11 | -$0.13 | 15.38% | |
| 1996-03-31 | 1996-04-17 | -$0.09 | -$0.13 | 30.77% | |
| 1995-12-31 | 1996-01-23 | -$0.11 | -$0.18 | 38.89% | |
| 1995-09-30 | 1995-10-23 | -$0.08 | -$0.14 | 42.86% |
Nektar Therapeutics (NKTR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Nektar Therapeutics (NKTR) Chart:
Nektar Therapeutics (NKTR) News:
Below you will find a list of latest news for Nektar Therapeutics (NKTR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Nektar Therapeutics (NKTR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 0.5 | 0.75 | CALL | 0 | 0 | 224.03 | TRUE | 0 | 0 |
| 2025-02-21 | 1 | 0.46 | CALL | 10 | 15 | 97.53 | TRUE | 0.46 | 0 |
| 2025-02-21 | 1.5 | 0.4 | CALL | 100 | 699 | 88.95 | FALSE | 0.15 | 0.6 |
| 2025-02-21 | 2 | 0.1 | CALL | 0 | 26 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 3 | 0.06 | CALL | 0 | 17 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 1 | 0.14 | PUT | 0 | 23 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 1.5 | 0.4 | PUT | 0 | 11 | 0 | TRUE | 0 | 0 |
| 2025-02-21 | 2 | 0 | PUT | 0 | 0 | 74.46 | TRUE | 0 | 0 |
| 2025-02-21 | 3 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-02-21 | 4 | 0 | PUT | 0 | 0 | 179.35 | TRUE | 0 | 0 |
| 2025-05-16 | 0.5 | 0.9 | CALL | 0 | 5 | 143.27 | TRUE | 0 | 0 |
| 2025-05-16 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-05-16 | 1.5 | 0.4 | CALL | 1 | 6 | 113.36 | FALSE | 0.4 | 0 |
| 2025-05-16 | 2 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 3 | 0.09 | CALL | 0 | 45 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 0.5 | 0.18 | PUT | 18 | 0 | 204.22 | FALSE | 0.18 | 0 |
| 2025-05-16 | 1 | 0.2 | PUT | 0 | 16 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 1.5 | 0 | PUT | 0 | 0 | 109.36 | TRUE | 0 | 0 |
| 2025-05-16 | 2 | 0 | PUT | 0 | 0 | 114.27 | TRUE | 0 | 0 |
| 2025-05-16 | 3 | 0 | PUT | 0 | 0 | 117.53 | TRUE | 0 | 0 |
| 2025-05-16 | 4 | 0 | PUT | 0 | 0 | 115.85 | TRUE | 0 | 0 |
Latest NKTR Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 44 | $3.175 |
| Jun 13, 2022 7:59 PM EST | 9 | $3.18 |
| Jun 13, 2022 7:59 PM EST | 32 | $3.18 |
| Jun 13, 2022 7:59 PM EST | 108 | $3.18 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.175 |
Nektar Therapeutics (NKTR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020015571/0001213900-20-015571-index.htm |
| 2019-02-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/906709/000000000019001648/0000000000-19-001648-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000021545719004874/0000215457-19-004874-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000031506619001215/0000315066-19-001215-index.htm |
| 2019-08-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000031506619001669/0000315066-19-001669-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000031506620001115/0000315066-20-001115-index.htm |
| 2020-03-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000031506620001364/0000315066-20-001364-index.htm |
| 2019-01-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000072888919000041/0000728889-19-000041-index.htm |
| 2019-11-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000083423719000296/0000834237-19-000296-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000083423720002313/0000834237-20-002313-index.htm |
| 2019-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000089924319024510/0000899243-19-024510-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000089924319024776/0000899243-19-024776-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000089924319024777/0000899243-19-024777-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000090221919000343/0000902219-19-000343-index.htm |
| 2020-01-27 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000090221920000156/0000902219-20-000156-index.htm |
| 2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/906709/000090670919000006/0000906709-19-000006-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/906709/000090670919000010/0000906709-19-000010-index.htm |
| 2020-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/906709/000090670920000004/0000906709-20-000004-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/906709/000090670920000009/0000906709-20-000009-index.htm |
| 2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/906709/000090670920000014/0000906709-20-000014-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/906709/000090670920000017/0000906709-20-000017-index.htm |
| 2019-06-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000091420819000306/0000914208-19-000306-index.htm |
| 2019-10-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000091420819000404/0000914208-19-000404-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000091420820000073/0000914208-20-000073-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000093247119005486/0000932471-19-005486-index.htm |
| 2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000110465919006809/0001104659-19-006809-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000110465920017871/0001104659-20-017871-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/906709/000110465920019090/0001104659-20-019090-index.htm |
| 2019-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000119312519029550/0001193125-19-029550-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/906709/000119312519129488/0001193125-19-129488-index.htm |
| 2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/906709/000119312519129523/0001193125-19-129523-index.htm |
| 2019-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000119312519315711/0001193125-19-315711-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/906709/000119312520126152/0001193125-20-126152-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/906709/000119312520126207/0001193125-20-126207-index.htm |
| 2020-08-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/906709/000119312520213033/0001193125-20-213033-index.htm |
| 2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919118063300/0001209191-18-063300-index.htm |
| 2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919118063301/0001209191-18-063301-index.htm |
| 2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919118063302/0001209191-18-063302-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119006044/0001209191-19-006044-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119007880/0001209191-19-007880-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119012332/0001209191-19-012332-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119012333/0001209191-19-012333-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119012334/0001209191-19-012334-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119012335/0001209191-19-012335-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119012336/0001209191-19-012336-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119012337/0001209191-19-012337-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119018968/0001209191-19-018968-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119031184/0001209191-19-031184-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119031185/0001209191-19-031185-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119031187/0001209191-19-031187-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119031188/0001209191-19-031188-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119031189/0001209191-19-031189-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119031190/0001209191-19-031190-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119032499/0001209191-19-032499-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119038099/0001209191-19-038099-index.htm |
| 2019-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119041725/0001209191-19-041725-index.htm |
| 2019-07-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119041988/0001209191-19-041988-index.htm |
| 2019-07-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119043289/0001209191-19-043289-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119046428/0001209191-19-046428-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119046714/0001209191-19-046714-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119046715/0001209191-19-046715-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119046718/0001209191-19-046718-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119046720/0001209191-19-046720-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119046722/0001209191-19-046722-index.htm |
| 2019-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119047423/0001209191-19-047423-index.htm |
| 2019-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119047553/0001209191-19-047553-index.htm |
| 2019-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119048922/0001209191-19-048922-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119050149/0001209191-19-050149-index.htm |
| 2019-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119050587/0001209191-19-050587-index.htm |
| 2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119051041/0001209191-19-051041-index.htm |
| 2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119051042/0001209191-19-051042-index.htm |
| 2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119051043/0001209191-19-051043-index.htm |
| 2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119051044/0001209191-19-051044-index.htm |
| 2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119051045/0001209191-19-051045-index.htm |
| 2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119051046/0001209191-19-051046-index.htm |
| 2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119051405/0001209191-19-051405-index.htm |
| 2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119051407/0001209191-19-051407-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119051968/0001209191-19-051968-index.htm |
| 2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119053497/0001209191-19-053497-index.htm |
| 2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119053498/0001209191-19-053498-index.htm |
| 2019-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119056807/0001209191-19-056807-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119057489/0001209191-19-057489-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119057490/0001209191-19-057490-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119057491/0001209191-19-057491-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119057492/0001209191-19-057492-index.htm |
| 2019-12-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119059173/0001209191-19-059173-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119059174/0001209191-19-059174-index.htm |
| 2019-12-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119060786/0001209191-19-060786-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119060787/0001209191-19-060787-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119060788/0001209191-19-060788-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119060789/0001209191-19-060789-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119060790/0001209191-19-060790-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119060791/0001209191-19-060791-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919119061643/0001209191-19-061643-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120007713/0001209191-20-007713-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120009818/0001209191-20-009818-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120011258/0001209191-20-011258-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120011261/0001209191-20-011261-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120011262/0001209191-20-011262-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120011263/0001209191-20-011263-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120019011/0001209191-20-019011-index.htm |
| 2020-04-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120023972/0001209191-20-023972-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120024928/0001209191-20-024928-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120031014/0001209191-20-031014-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120031015/0001209191-20-031015-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120031016/0001209191-20-031016-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120031017/0001209191-20-031017-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120031018/0001209191-20-031018-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120042219/0001209191-20-042219-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120042220/0001209191-20-042220-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120047613/0001209191-20-047613-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120047615/0001209191-20-047615-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120047617/0001209191-20-047617-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120047619/0001209191-20-047619-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120047620/0001209191-20-047620-index.htm |
| 2020-09-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120049782/0001209191-20-049782-index.htm |
| 2020-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120050074/0001209191-20-050074-index.htm |
| 2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120051388/0001209191-20-051388-index.htm |
| 2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120051389/0001209191-20-051389-index.htm |
| 2020-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052039/0001209191-20-052039-index.htm |
| 2020-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052040/0001209191-20-052040-index.htm |
| 2020-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052041/0001209191-20-052041-index.htm |
| 2020-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052042/0001209191-20-052042-index.htm |
| 2020-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052043/0001209191-20-052043-index.htm |
| 2020-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052044/0001209191-20-052044-index.htm |
| 2020-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052045/0001209191-20-052045-index.htm |
| 2020-09-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052150/0001209191-20-052150-index.htm |
| 2020-09-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052152/0001209191-20-052152-index.htm |
| 2020-09-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052153/0001209191-20-052153-index.htm |
| 2020-09-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052154/0001209191-20-052154-index.htm |
| 2020-09-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052155/0001209191-20-052155-index.htm |
| 2020-09-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052156/0001209191-20-052156-index.htm |
| 2020-09-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052158/0001209191-20-052158-index.htm |
| 2020-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052159/0001209191-20-052159-index.htm |
| 2020-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/906709/000120919120052511/0001209191-20-052511-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390019010823/0001213900-19-010823-index.htm |
| 2019-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390019013563/0001213900-19-013563-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390019014971/0001213900-19-014971-index.htm |
| 2019-08-30 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390019016964/0001213900-19-016964-index.htm |
| 2019-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390019019363/0001213900-19-019363-index.htm |
| 2019-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390019020743/0001213900-19-020743-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390019022213/0001213900-19-022213-index.htm |
| 2019-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390019024088/0001213900-19-024088-index.htm |
| 2019-12-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390019025345/0001213900-19-025345-index.htm |
| 2019-12-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390019025561/0001213900-19-025561-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020000720/0001213900-20-000720-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020000838/0001213900-20-000838-index.htm |
| 2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020001039/0001213900-20-001039-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020004909/0001213900-20-004909-index.htm |
| 2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020008413/0001213900-20-008413-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020011292/0001213900-20-011292-index.htm |
| 2020-06-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020015571/0001213900-20-015571-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020020655/0001213900-20-020655-index.htm |
| 2020-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020029722/0001213900-20-029722-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000121390020035296/0001213900-20-035296-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/906709/000156459019005639/0001564590-19-005639-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/906709/000156459019017467/0001564590-19-017467-index.htm |
| 2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000161577419000242/0001615774-19-000242-index.htm |
| 2019-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000161577419000329/0001615774-19-000329-index.htm |
| 2019-02-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000161577419002632/0001615774-19-002632-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000161577419003356/0001615774-19-003356-index.htm |
| 2019-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000161577419003462/0001615774-19-003462-index.htm |
| 2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000161577419007051/0001615774-19-007051-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/906709/000161577419007301/0001615774-19-007301-index.htm |
Nektar Therapeutics (NKTR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nektar Therapeutics (NKTR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 87%Institutional Ownership: 9779%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-09-05 | Stephen K Doberstein | SVP & Chief Scientific Officer | Buy | 15,000.00 | 17.28 | 259,200.00 | 107,668.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119048922/0001209191-19-048922-index.htm |
| 2019-12-12 | Curet Myriam | Director | Buy | 11,700.00 | 11,700.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119060791/0001209191-19-060791-index.htm | ||
| 2019-08-16 | Gil M Labrucherie | SVP & Chief Financial Officer | Sell | 5,063.00 | 18.15 | 91,893.45 | 122,872.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119046715/0001209191-19-046715-index.htm |
| 2019-05-16 | Gil M Labrucherie | SVP & Chief Financial Officer | Sell | 3,767.00 | 31.37 | 118,170.79 | 127,935.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119031187/0001209191-19-031187-index.htm |
| 2019-06-17 | Gil M Labrucherie | SVP & Chief Financial Officer | Sell | 25,000.00 | 33.71 | 842,750.00 | 127,935.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119038099/0001209191-19-038099-index.htm |
| 2019-07-10 | Gil M Labrucherie | SVP & Chief Financial Officer | Sell | 25,000.00 | 34.57 | 864,250.00 | 127,935.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119041988/0001209191-19-041988-index.htm |
| 2019-08-14 | Gil M Labrucherie | SVP & Chief Financial Officer | Sell | 25,000.00 | 17.79 | 444,750.00 | 127,935.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119046428/0001209191-19-046428-index.htm |
| 2019-02-19 | Gil M Labrucherie | SVP & Chief Financial Officer | Sell | 3,592.00 | 42.39 | 152,264.88 | 131,702.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012334/0001209191-19-012334-index.htm |
| 2018-12-14 | Gil M Labrucherie | SVP & Chief Financial Officer | Buy | 28,750.00 | 135,294.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919118063300/0001209191-18-063300-index.htm | ||
| 2019-03-08 | R SCOTT GREER | Director | Buy | 10,000.00 | 5.14 | 51,400.00 | 145,083.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119018968/0001209191-19-018968-index.htm |
| 2019-09-25 | KARIN EASTHAM | Director | Buy | 6,500.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119051043/0001209191-19-051043-index.htm | ||
| 2019-09-25 | R SCOTT GREER | Director | Buy | 6,500.00 | 151,583.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119051044/0001209191-19-051044-index.htm | ||
| 2019-08-26 | Gil M Labrucherie | SVP & Chief Financial Officer | Buy | 30,000.00 | 16.31 | 489,300.00 | 152,872.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119047553/0001209191-19-047553-index.htm |
| 2019-09-16 | Gil M Labrucherie | SVP & Chief Financial Officer | Sell | 25,000.00 | 20.52 | 513,000.00 | 152,872.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119050149/0001209191-19-050149-index.htm |
| 2019-06-17 | Gil M Labrucherie | SVP & Chief Financial Officer | Buy | 25,000.00 | 7.21 | 180,250.00 | 152,935.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119038099/0001209191-19-038099-index.htm |
| 2019-07-10 | Gil M Labrucherie | SVP & Chief Financial Officer | Buy | 25,000.00 | 7.21 | 180,250.00 | 152,935.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119041988/0001209191-19-041988-index.htm |
| 2019-08-14 | Gil M Labrucherie | SVP & Chief Financial Officer | Buy | 25,000.00 | 7.21 | 180,250.00 | 152,935.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119046428/0001209191-19-046428-index.htm |
| 2019-11-18 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Sell | 2,713.00 | 17.97 | 48,752.61 | 160,441.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119057491/0001209191-19-057491-index.htm |
| 2019-08-16 | John Nicholson | SVP & Chief Operating Officer | Sell | 3,819.00 | 18.15 | 69,314.85 | 162,759.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119046718/0001209191-19-046718-index.htm |
| 2019-08-16 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Sell | 1,809.00 | 18.15 | 32,833.35 | 163,154.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119046722/0001209191-19-046722-index.htm |
| 2019-05-16 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Sell | 1,928.00 | 31.37 | 60,481.36 | 164,463.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119031190/0001209191-19-031190-index.htm |
| 2019-02-19 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Sell | 1,808.00 | 42.39 | 76,641.12 | 166,391.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012337/0001209191-19-012337-index.htm |
| 2019-05-16 | John Nicholson | SVP & Chief Operating Officer | Sell | 4,077.00 | 31.37 | 127,895.49 | 166,578.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119031188/0001209191-19-031188-index.htm |
| 2018-12-14 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Buy | 10,950.00 | 168,199.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919118063302/0001209191-18-063302-index.htm | ||
| 2019-02-04 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Sell | 16,119.00 | 42.16 | 679,577.04 | 168,199.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119007880/0001209191-19-007880-index.htm |
| 2019-02-19 | John Nicholson | SVP & Chief Operating Officer | Sell | 3,822.00 | 42.39 | 162,014.58 | 170,655.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012335/0001209191-19-012335-index.htm |
| 2020-08-17 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Sell | 1,367.00 | 19.67 | 26,888.89 | 171,733.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120047617/0001209191-20-047617-index.htm |
| 2020-05-18 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Sell | 1,367.00 | 22.51 | 30,771.17 | 172,719.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120031016/0001209191-20-031016-index.htm |
| 2020-02-18 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Sell | 1,394.00 | 22.35 | 31,155.90 | 174,086.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120011262/0001209191-20-011262-index.htm |
| 2019-01-28 | John Nicholson | SVP & Chief Operating Officer | Sell | 63,000.00 | 42.82 | 2,697,660.00 | 174,477.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119006044/0001209191-19-006044-index.htm |
| 2019-12-12 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Buy | 14,900.00 | 175,480.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119060789/0001209191-19-060789-index.htm | ||
| 2020-02-06 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Sell | 37,500.00 | 22.78 | 854,250.00 | 175,480.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120007713/0001209191-20-007713-index.htm |
| 2020-07-09 | R SCOTT GREER | Director | Sell | 15,009.00 | 25.00 | 375,225.00 | 176,574.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120042220/0001209191-20-042220-index.htm |
| 2019-09-16 | Gil M Labrucherie | SVP & Chief Financial Officer | Buy | 25,000.00 | 7.21 | 180,250.00 | 177,872.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119050149/0001209191-19-050149-index.htm |
| 2019-09-20 | Jeffrey Robert Ajer | Director | Sell | 2,250.00 | 20.24 | 45,540.00 | 18,250.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119050587/0001209191-19-050587-index.htm |
| 2019-02-04 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Buy | 16,119.00 | 10.69 | 172,312.11 | 184,318.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119007880/0001209191-19-007880-index.htm |
| 2020-09-22 | R SCOTT GREER | Director | Buy | 9,100.00 | 185,674.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120052043/0001209191-20-052043-index.htm | ||
| 2019-09-25 | ROY A WHITFIELD | Director | Buy | 6,500.00 | 188,250.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119051046/0001209191-19-051046-index.htm | ||
| 2020-07-09 | R SCOTT GREER | Director | Buy | 40,000.00 | 9.24 | 369,600.00 | 191,583.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120042220/0001209191-20-042220-index.htm |
| 2019-12-18 | ROY A WHITFIELD | Director | Buy | 10,000.00 | 9.24 | 92,400.00 | 198,250.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119061643/0001209191-19-061643-index.htm |
| 2019-12-02 | JOHN NORTHCOTT | SVP & Chief Commercial Officer | Buy | 200,000.00 | 200,000.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119059174/0001209191-19-059174-index.htm | ||
| 2020-09-21 | Jeffrey Robert Ajer | Director | Sell | 2,250.00 | 19.74 | 44,415.00 | 20,125.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120051388/0001209191-20-051388-index.htm |
| 2020-09-22 | Curet Myriam | Director | Buy | 9,100.00 | 20,800.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120052041/0001209191-20-052041-index.htm | ||
| 2020-02-06 | Jillian B. Thomsen | SVP & Chief Accounting Officer | Buy | 37,500.00 | 7.21 | 270,375.00 | 212,980.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120007713/0001209191-20-007713-index.htm |
| 2019-11-18 | Gil M Labrucherie | SVP, COO & CFO | Sell | 8,863.00 | 17.97 | 159,268.11 | 219,009.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119057489/0001209191-19-057489-index.htm |
| 2019-09-30 | Jeffrey Robert Ajer | Director | Sell | 2,375.00 | 18.06 | 42,892.50 | 22,375.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119051407/0001209191-19-051407-index.htm |
| 2019-10-01 | Gil M Labrucherie | SVP, COO & CFO | Buy | 75,000.00 | 227,872.00 | https://www.sec.gov/Archives/edgar/data/906709/000089924319024776/0000899243-19-024776-index.htm | ||
| 2019-10-15 | Gil M Labrucherie | SVP, COO & CFO | Sell | 25,000.00 | 15.83 | 395,750.00 | 227,872.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119053497/0001209191-19-053497-index.htm |
| 2019-11-13 | Gil M Labrucherie | SVP, COO & CFO | Sell | 25,000.00 | 19.79 | 494,750.00 | 227,872.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119056807/0001209191-19-056807-index.htm |
| 2020-09-04 | ROY A WHITFIELD | Director | Buy | 30,000.00 | 9.24 | 277,200.00 | 228,250.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120049782/0001209191-20-049782-index.htm |
| 2019-07-08 | Lutz Lingnau | Director | Sell | 10,000.00 | 34.63 | 346,300.00 | 23,200.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119041725/0001209191-19-041725-index.htm |
| 2020-09-17 | Gil M Labrucherie | SVP, COO & CFO | Sell | 2,000.00 | 19.96 | 39,920.00 | 235,249.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120051389/0001209191-20-051389-index.htm |
| 2020-08-18 | Gil M Labrucherie | SVP, COO & CFO | Sell | 2,000.00 | 19.68 | 39,360.00 | 237,249.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120047613/0001209191-20-047613-index.htm |
| 2020-09-22 | ROY A WHITFIELD | Director | Buy | 9,100.00 | 237,350.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120052045/0001209191-20-052045-index.htm | ||
| 2019-01-28 | John Nicholson | SVP & Chief Operating Officer | Buy | 63,000.00 | 10.69 | 673,470.00 | 237,477.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119006044/0001209191-19-006044-index.htm |
| 2020-08-17 | Gil M Labrucherie | SVP, COO & CFO | Sell | 6,245.00 | 19.67 | 122,839.15 | 239,249.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120047613/0001209191-20-047613-index.htm |
| 2020-09-22 | KARIN EASTHAM | Director | Buy | 9,100.00 | 24,100.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120052042/0001209191-20-052042-index.htm | ||
| 2020-05-19 | Gil M Labrucherie | SVP, COO & CFO | Sell | 2,000.00 | 22.62 | 45,240.00 | 245,494.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120031014/0001209191-20-031014-index.htm |
| 2020-05-18 | Gil M Labrucherie | SVP, COO & CFO | Sell | 5,727.00 | 22.51 | 128,914.77 | 247,494.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120031014/0001209191-20-031014-index.htm |
| 2019-09-25 | Jeffrey Robert Ajer | Director | Buy | 6,500.00 | 24,750.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119051041/0001209191-19-051041-index.htm | ||
| 2019-10-15 | Gil M Labrucherie | SVP, COO & CFO | Buy | 25,000.00 | 7.21 | 180,250.00 | 252,872.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119053497/0001209191-19-053497-index.htm |
| 2019-11-13 | Gil M Labrucherie | SVP, COO & CFO | Buy | 25,000.00 | 7.21 | 180,250.00 | 252,872.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119056807/0001209191-19-056807-index.htm |
| 2020-02-18 | Gil M Labrucherie | SVP, COO & CFO | Sell | 5,938.00 | 22.35 | 132,714.30 | 253,221.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120011258/0001209191-20-011258-index.htm |
| 2019-12-12 | Gil M Labrucherie | SVP, COO & CFO | Buy | 40,150.00 | 259,159.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119060787/0001209191-19-060787-index.htm | ||
| 2020-09-28 | Jeffrey Robert Ajer | Director | Sell | 3,250.00 | 17.25 | 56,062.50 | 25,975.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120052511/0001209191-20-052511-index.htm |
| 2019-09-27 | Lutz Lingnau | Director | Sell | 3,000.00 | 17.84 | 53,520.00 | 26,700.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119051968/0001209191-19-051968-index.htm |
| 2019-09-27 | ROBERT CHESS | Director | Sell | 4,000.00 | 17.99 | 71,960.00 | 276,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119051405/0001209191-19-051405-index.htm |
| 2020-02-12 | ROBERT CHESS | Director | Sell | 3,599.00 | 23.72 | 85,368.28 | 276,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120009818/0001209191-20-009818-index.htm |
| 2020-03-11 | ROBERT CHESS | Director | Sell | 1,200.00 | 17.41 | 20,892.00 | 276,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120019011/0001209191-20-019011-index.htm |
| 2020-04-15 | ROBERT CHESS | Director | Sell | 197.00 | 19.02 | 3,746.94 | 276,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120024928/0001209191-20-024928-index.htm |
| 2020-07-08 | ROBERT CHESS | Director | Sell | 8,000.00 | 24.58 | 196,640.00 | 276,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120042219/0001209191-20-042219-index.htm |
| 2020-09-08 | ROBERT CHESS | Director | Sell | 8,000.00 | 18.53 | 148,240.00 | 276,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120050074/0001209191-20-050074-index.htm |
| 2020-04-15 | ROBERT CHESS | Director | Sell | 7,803.00 | 18.36 | 143,263.08 | 277,170.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120024928/0001209191-20-024928-index.htm |
| 2020-03-11 | ROBERT CHESS | Director | Sell | 6,800.00 | 16.68 | 113,424.00 | 278,173.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120019011/0001209191-20-019011-index.htm |
| 2020-02-12 | ROBERT CHESS | Director | Sell | 4,401.00 | 23.32 | 102,631.32 | 280,572.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120009818/0001209191-20-009818-index.htm |
| 2020-09-25 | ROBERT CHESS | Director | Sell | 5,500.00 | 17.75 | 97,625.00 | 280,573.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120052159/0001209191-20-052159-index.htm |
| 2019-09-25 | ROBERT CHESS | Director | Buy | 6,500.00 | 280,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119051042/0001209191-19-051042-index.htm | ||
| 2019-08-16 | HOWARD W ROBIN | President & CEO | Sell | 12,551.00 | 18.15 | 227,800.65 | 282,775.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119046720/0001209191-19-046720-index.htm |
| 2020-07-08 | ROBERT CHESS | Director | Buy | 8,000.00 | 9.24 | 73,920.00 | 284,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120042219/0001209191-20-042219-index.htm |
| 2020-09-08 | ROBERT CHESS | Director | Buy | 8,000.00 | 9.24 | 73,920.00 | 284,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120050074/0001209191-20-050074-index.htm |
| 2020-02-12 | ROBERT CHESS | Director | Sell | 8,000.00 | 9.24 | 73,920.00 | 284,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120009818/0001209191-20-009818-index.htm |
| 2020-03-11 | ROBERT CHESS | Director | Sell | 8,000.00 | 9.24 | 73,920.00 | 284,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120019011/0001209191-20-019011-index.htm |
| 2020-04-15 | ROBERT CHESS | Director | Sell | 8,000.00 | 9.24 | 73,920.00 | 284,973.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120024928/0001209191-20-024928-index.htm |
| 2020-09-22 | ROBERT CHESS | Director | Buy | 9,100.00 | 286,073.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120052040/0001209191-20-052040-index.htm | ||
| 2019-11-18 | Jonathan Zalevsky | Chief R&D Officer | Sell | 3,960.00 | 17.97 | 71,161.20 | 291,697.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119057492/0001209191-19-057492-index.htm |
| 2020-09-22 | Jeffrey Robert Ajer | Director | Buy | 9,100.00 | 29,225.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120052039/0001209191-20-052039-index.htm | ||
| 2019-05-16 | HOWARD W ROBIN | President & CEO | Sell | 13,383.00 | 31.37 | 419,824.71 | 295,326.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119031189/0001209191-19-031189-index.htm |
| 2019-05-21 | HOWARD W ROBIN | President & CEO | Sell | 33,333.00 | 32.93 | 1,097,655.69 | 295,326.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119032499/0001209191-19-032499-index.htm |
| 2019-05-22 | HOWARD W ROBIN | President & CEO | Sell | 33,334.00 | 33.38 | 1,112,688.92 | 295,326.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119032499/0001209191-19-032499-index.htm |
| 2019-05-23 | HOWARD W ROBIN | President & CEO | Sell | 33,333.00 | 32.69 | 1,089,655.77 | 295,326.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119032499/0001209191-19-032499-index.htm |
| 2019-07-23 | HOWARD W ROBIN | President & CEO | Sell | 33,333.00 | 32.10 | 1,069,989.30 | 295,326.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119043289/0001209191-19-043289-index.htm |
| 2019-07-24 | HOWARD W ROBIN | President & CEO | Sell | 33,334.00 | 32.11 | 1,070,354.74 | 295,326.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119043289/0001209191-19-043289-index.htm |
| 2019-07-25 | HOWARD W ROBIN | President & CEO | Sell | 33,333.00 | 29.65 | 988,323.45 | 295,326.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119043289/0001209191-19-043289-index.htm |
| 2019-10-01 | Jonathan Zalevsky | Chief R&D Officer | Buy | 75,000.00 | 295,657.00 | https://www.sec.gov/Archives/edgar/data/906709/000089924319024777/0000899243-19-024777-index.htm | ||
| 2020-08-17 | Jonathan Zalevsky | Chief R&D Officer | Sell | 26,200.00 | 19.67 | 515,354.00 | 296,315.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120047620/0001209191-20-047620-index.htm |
| 2019-09-25 | Lutz Lingnau | Director | Buy | 6,500.00 | 29,700.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119051045/0001209191-19-051045-index.htm | ||
| 2019-11-18 | HOWARD W ROBIN | President & CEO | Sell | 13,556.00 | 17.97 | 243,601.32 | 299,219.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119057490/0001209191-19-057490-index.htm |
| 2019-02-19 | HOWARD W ROBIN | President & CEO | Sell | 8,882.00 | 42.39 | 376,507.98 | 308,709.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012336/0001209191-19-012336-index.htm |
| 2019-02-20 | HOWARD W ROBIN | President & CEO | Sell | 33,334.00 | 43.20 | 1,440,028.80 | 308,709.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012336/0001209191-19-012336-index.htm |
| 2019-02-21 | HOWARD W ROBIN | President & CEO | Sell | 33,333.00 | 41.01 | 1,366,986.33 | 308,709.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012336/0001209191-19-012336-index.htm |
| 2019-08-23 | HOWARD W ROBIN | President & CEO | Buy | 30,000.00 | 16.31 | 489,300.00 | 312,775.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119047423/0001209191-19-047423-index.htm |
| 2019-10-15 | HOWARD W ROBIN | President & CEO | Sell | 24,500.00 | 17.17 | 420,665.00 | 312,775.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119053498/0001209191-19-053498-index.htm |
| 2019-10-16 | HOWARD W ROBIN | President & CEO | Sell | 33,334.00 | 17.48 | 582,678.32 | 312,775.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119053498/0001209191-19-053498-index.htm |
| 2019-10-17 | HOWARD W ROBIN | President & CEO | Sell | 33,333.00 | 17.68 | 589,327.44 | 312,775.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119053498/0001209191-19-053498-index.htm |
| 2018-12-14 | HOWARD W ROBIN | President & CEO | Buy | 68,450.00 | 317,591.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919118063301/0001209191-18-063301-index.htm | ||
| 2019-02-19 | HOWARD W ROBIN | President & CEO | Sell | 33,333.00 | 42.32 | 1,410,652.56 | 317,591.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012336/0001209191-19-012336-index.htm |
| 2020-05-18 | Jonathan Zalevsky | Chief R&D Officer | Sell | 4,558.00 | 22.51 | 102,600.58 | 322,515.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120031018/0001209191-20-031018-index.htm |
| 2020-02-18 | Jonathan Zalevsky | Chief R&D Officer | Sell | 4,774.00 | 22.35 | 106,698.90 | 327,073.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120011263/0001209191-20-011263-index.htm |
| 2019-05-21 | HOWARD W ROBIN | President & CEO | Buy | 33,333.00 | 7.21 | 240,330.93 | 328,659.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119032499/0001209191-19-032499-index.htm |
| 2019-05-23 | HOWARD W ROBIN | President & CEO | Buy | 33,333.00 | 7.21 | 240,330.93 | 328,659.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119032499/0001209191-19-032499-index.htm |
| 2019-07-23 | HOWARD W ROBIN | President & CEO | Buy | 33,333.00 | 7.21 | 240,330.93 | 328,659.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119043289/0001209191-19-043289-index.htm |
| 2019-07-25 | HOWARD W ROBIN | President & CEO | Buy | 33,333.00 | 7.21 | 240,330.93 | 328,659.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119043289/0001209191-19-043289-index.htm |
| 2019-05-22 | HOWARD W ROBIN | President & CEO | Buy | 33,334.00 | 7.21 | 240,338.14 | 328,660.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119032499/0001209191-19-032499-index.htm |
| 2019-07-24 | HOWARD W ROBIN | President & CEO | Buy | 33,334.00 | 7.21 | 240,338.14 | 328,660.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119043289/0001209191-19-043289-index.htm |
| 2019-12-12 | Jonathan Zalevsky | Chief R&D Officer | Buy | 40,150.00 | 331,847.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119060790/0001209191-19-060790-index.htm | ||
| 2019-07-08 | Lutz Lingnau | Director | Buy | 10,000.00 | 9.24 | 92,400.00 | 33,200.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119041725/0001209191-19-041725-index.htm |
| 2019-10-15 | HOWARD W ROBIN | President & CEO | Sell | 8,833.00 | 16.35 | 144,419.55 | 337,275.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119053498/0001209191-19-053498-index.htm |
| 2019-02-21 | HOWARD W ROBIN | President & CEO | Buy | 33,333.00 | 7.21 | 240,330.93 | 342,042.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012336/0001209191-19-012336-index.htm |
| 2019-02-20 | HOWARD W ROBIN | President & CEO | Buy | 33,334.00 | 7.21 | 240,338.14 | 342,043.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012336/0001209191-19-012336-index.htm |
| 2019-10-15 | HOWARD W ROBIN | President & CEO | Buy | 33,333.00 | 7.21 | 240,330.93 | 346,108.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119053498/0001209191-19-053498-index.htm |
| 2019-10-17 | HOWARD W ROBIN | President & CEO | Buy | 33,333.00 | 7.21 | 240,330.93 | 346,108.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119053498/0001209191-19-053498-index.htm |
| 2019-10-16 | HOWARD W ROBIN | President & CEO | Buy | 33,334.00 | 7.21 | 240,338.14 | 346,109.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119053498/0001209191-19-053498-index.htm |
| 2019-02-19 | HOWARD W ROBIN | President & CEO | Buy | 33,333.00 | 7.21 | 240,330.93 | 350,924.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012336/0001209191-19-012336-index.htm |
| 2020-09-22 | Lutz Lingnau | Director | Buy | 9,100.00 | 35,800.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120052044/0001209191-20-052044-index.htm | ||
| 2020-08-17 | HOWARD W ROBIN | President & CEO | Sell | 11,885.00 | 19.67 | 233,777.95 | 364,018.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120047615/0001209191-20-047615-index.htm |
| 2020-05-18 | HOWARD W ROBIN | President & CEO | Sell | 8,968.00 | 22.51 | 201,869.68 | 375,903.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120031015/0001209191-20-031015-index.htm |
| 2020-02-18 | HOWARD W ROBIN | President & CEO | Sell | 8,448.00 | 22.35 | 188,812.80 | 384,871.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120011261/0001209191-20-011261-index.htm |
| 2019-12-12 | HOWARD W ROBIN | President & CEO | Buy | 94,100.00 | 393,319.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119060788/0001209191-19-060788-index.htm | ||
| 2020-08-17 | Mark Andrew Wilson | SVP & General Counsel | Sell | 1,529.00 | 19.67 | 30,075.43 | 51,389.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120047619/0001209191-20-047619-index.htm |
| 2020-05-18 | Mark Andrew Wilson | SVP & General Counsel | Sell | 1,529.00 | 22.51 | 34,417.79 | 52,418.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919120031017/0001209191-20-031017-index.htm |
| 2019-08-16 | Stephen K Doberstein | SVP & Chief Scientific Officer | Sell | 3,245.00 | 18.15 | 58,896.75 | 92,668.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119046714/0001209191-19-046714-index.htm |
| 2019-05-16 | Maninder Hora | SVP Pharma Dev & Mfg Ops | Sell | 2,449.00 | 31.37 | 76,825.13 | 94,694.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119031185/0001209191-19-031185-index.htm |
| 2019-05-16 | Stephen K Doberstein | SVP & Chief Scientific Officer | Sell | 3,461.00 | 31.37 | 108,571.57 | 95,913.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119031184/0001209191-19-031184-index.htm |
| 2019-02-19 | Maninder Hora | SVP Pharma Dev & Mfg Ops | Sell | 2,386.00 | 42.39 | 101,142.54 | 97,143.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012333/0001209191-19-012333-index.htm |
| 2019-02-19 | Stephen K Doberstein | SVP & Chief Scientific Officer | Sell | 3,310.00 | 42.39 | 140,310.90 | 99,374.00 | https://www.sec.gov/Archives/edgar/data/906709/000120919119012332/0001209191-19-012332-index.htm |